Clinical Trial Update: Safety and Efficacy of OBX-115 in Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update indicates OBX-115 is being studied in advanced solid tumors in Phase 1 and Phase 2, with recruitment ongoing for indications including m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma
• Non-small Cell Lung Cancer

Drugs mentioned

• OBX-115

Snippet

Sponsor: Obsidian Therapeutics, Inc. | Conditions: Tumor Skin, Metastatic Melanoma | Phase 1, Phase 2 | Status: RECRUITING